832 F.Supp. 1467 (M.D.Fla. 1993), 89-1705-CIV-T-23, Walls v. Armour Pharmaceutical Co.
Linked as:
Extract
832 F.Supp. 1467 (M.D.Fla. 1993), 89-1705-CIV-T-23, Walls v. Armour Pharmaceutical Co.
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Mailing of important information about drugs
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products described in section 201.56(b)(1)
- Code of Federal Regulations - Changes to an approved application
- US Code - 21 U.S.C. § 301 Short Title
- US Code - 21 U.S.C. § 321 Definitions; Generally